CVS GROUP PLC — Director's Dealing 2026

May 28, 2026

National Storage Mechanism | Additional information

RNS Number : 9272F

CVS Group plc

28 May 2026

28 May 2026

CVS Group plc

("CVS" or the "Company")

PDMR Dealing

CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 27 May 2026 that Scott Morrison, Group General Counsel and Company Secretary of CVS, purchased a total of 987 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.

As a result, Scott Morrison's total interest in the Company, including all persons closely associated, is now at 987 Ordinary Shares, representing 0.001% per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc                                                                                                                               via FGS Global

Richard Fairman, CEO

Scott Morrison, Company Secretary

FGS Global (Financial PR)                                                                                             

Faeth Birch                                                                                                                                   +44 (0)207 251 3801

Charlie Chichester                                                                                                           [email protected]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Scott Morrison

2

Reason for the notification

a)

Position/status

PDMR (Group General Counsel and Company Secretary)

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.2 pence each

GB00B2863827

b)

Nature of the transaction

On-market purchase

c)

Price(s) and volume(s)

Price(s) - pence	Volume(s)
1,269.681	987

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

27 May 2026

f)

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHLDLFLQELZBBX